55 Hudson Yards Lands Its Fifth Tenant
Want to get a jump start on upcoming deals? Meet the major New York City players at one of our upcoming events!
Intercept Pharmaceuticals has signed an 85k SF lease for the 23rd through 25th floors of 55 Hudson Yards (pictured), making it the fifth firm to take space at the 51-story, 1.3M SF tower, after Boies, Schiller & Flexner, Point72, MarketAxxess and Milbank, The Real Deal reports.
The $2.6B pharma firm, currently in the Meatpacking District, also signed a 49k SF lease for the 40th floor of the 1.7M SF 10 Hudson Yards—the only completed building in Hudson Yards—where it will continue its research on liver disease while 55 Hudson Yards is constructed.
Newmark Grubb Knight Frank’s Paul Ippolito, Ira Rovitz and Seth Weinstein repped Intercept, while Related’s Stephen Winter repped the landlord in-house alongside CBRE’s Robert Alexander, Howard Fiddle and Emily Jones. [TRD]